Home › Companies › Editas Medicine, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Editas Medicine, Inc.’s Form 8-K, filed 2026-06-18 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Editas Medicine, Inc. in the interactive database Compare manager voting policies
These tallies are Editas Medicine, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-18 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Bernadette Connaughton | 28,660,181 | -- | -- | 10,789,549 | 26,404,190 | Majority: yes |
| Elect Director: Elliott Levy, M.D. | 37,095,058 | -- | -- | 2,354,672 | 26,404,190 | Majority: yes |
| Proposal 2: The Company's stockholders approved, on an advisory basis, the compensation paid to its named executive officers. | 32,914,258 | 6,322,885 | 212,587 | -- | 26,404,190 | Majority: yes |
| Proposal 3: The Company's stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | 64,686,839 | 774,471 | 392,610 | -- | 0 | Majority: yes |
Source: Editas Medicine, Inc., Form 8-K, filed with the SEC on 2026-06-18 — read the filing on EDGAR.
Each item below shows how the 237 asset managers that disclosed a Editas Medicine, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 8 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Editas Medicine, Inc.’s own tally for this item (“Proposal 2: The Company's stockholders approved, on an advisory basis, the compensation paid to its named executive officers.”): 32,914,258 for, 6,322,885 against, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 97,866,996 outstanding shares: 34% for, 6% against (40% of the company cast a for/against vote).
The 235 asset managers below cast 83% of the shares they voted on this item FOR (29,051,926 for, 5,902,055 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,983,857 | 34,039 | 1 | 0 | For |
| BlackRock | 5,538,903 | 1,571 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,451,963 | 0 | 0 | 0 | For |
| Fidelity | 2,240,731 | 42,900 | 0 | 0 | For |
| Nuveen | 1,977,509 | 0 | 0 | 0 | For |
| TIAA | 1,903,318 | 0 | 0 | 0 | For |
| Charles Schwab | 1,725,316 | 0 | 0 | 0 | For |
| State Street | 1,409,421 | 8,045 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 1,108,735 | 0 | 0 | Against |
| KENNEDY CAPITAL MANAGEMENT LLC | 0 | 871,149 | 0 | 0 | Against |
| MACKENZIE FINANCIAL CORP | 664,662 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 589,886 | 0 | 0 | Against |
| JPMorgan | 588,540 | 0 | 0 | 0 | For |
| DE Shaw | 0 | 407,973 | 0 | 0 | Against |
| TRUST CO OF OKLAHOMA | 392,550 | 0 | 0 | 0 | For |
| AQR | 0 | 392,280 | 0 | 0 | Against |
| Goldman Sachs | 312,083 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 260,507 | 0 | 0 | Against |
| Equitable | 154,726 | 104,610 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 247,091 | 0 | 0 | 0 | For |
| SEI | 218,332 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 167,530 | 0 | 0 | Against |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 151,743 | 0 | 0 | Against |
| Brighthouse | 77,282 | 46,299 | 9,034 | 0 | For |
| Lincoln Financial | 127,677 | 0 | 0 | 0 | For |
Showing the 25 largest of 235 asset managers. See all 235 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Editas Medicine, Inc.’s own tally for this item (“Proposal 3: The Company's stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”): 64,686,839 for, 774,471 against, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 97,866,996 outstanding shares: 66% for, 0.8% against (67% of the company cast a for/against vote).
The 47 asset managers below cast 99.9% of the shares they voted on this item FOR (16,735,025 for, 1 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,326,835 | 1 | 0 | 0 | For |
| Fidelity | 2,183,498 | 0 | 0 | 0 | For |
| BlackRock | 1,960,033 | 0 | 0 | 0 | For |
| TIAA | 1,903,318 | 0 | 0 | 0 | For |
| Charles Schwab | 862,565 | 0 | 0 | 0 | For |
| JPMorgan | 588,540 | 0 | 0 | 0 | For |
| Equitable | 259,336 | 0 | 0 | 0 | For |
| Brighthouse | 123,581 | 0 | 9,034 | 0 | For |
| Lincoln Financial | 127,677 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 126,000 | 0 | 0 | 0 | For |
| SEI | 108,986 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,885 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 104,989 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 95,483 | 0 | 0 | 0 | For |
| Global X | 92,273 | 0 | 0 | 0 | For |
| Nationwide | 90,079 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 64,082 | 0 | 0 | 0 | For |
| Voya | 57,070 | 0 | 0 | 0 | For |
| Northern Trust | 55,991 | 0 | 0 | 0 | For |
| T. Rowe Price | 55,067 | 0 | 0 | 0 | For |
| AQR | 41,896 | 0 | 0 | 0 | For |
| Pacific Life | 40,292 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Goldman Sachs | 37,079 | 0 | 0 | 0 | For |
| Russell Investments | 36,657 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Combines 6 wordings of this item as funds reported it.
73% Majority: yes · of votes cast
Editas Medicine, Inc.’s own tally for this item (“Elect Director: Bernadette Connaughton”): 28,660,181 for, 10,789,549 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 97,866,996 outstanding shares: 29% for, 11% withheld (40% of the company cast a for/withheld vote).
The 46 asset managers below cast 100% of the shares they voted on this item FOR (13,679,209 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,313,083 | 0 | 13,754 | 0 | For |
| Fidelity | 2,140,598 | 0 | 42,900 | 0 | For |
| BlackRock | 306,602 | 0 | 1,653,431 | 0 | Abstain |
| TIAA | 1,903,318 | 0 | 0 | 0 | For |
| Charles Schwab | 862,565 | 0 | 0 | 0 | For |
| JPMorgan | 588,540 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 259,336 | 0 | Abstain |
| Brighthouse | 77,282 | 0 | 55,333 | 0 | For |
| Lincoln Financial | 127,677 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 126,000 | 0 | Abstain |
| SEI | 108,986 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 108,885 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 104,989 | 0 | Abstain |
| Columbia Threadneedle | 0 | 0 | 95,483 | 0 | Abstain |
| Global X | 92,273 | 0 | 0 | 0 | For |
| Nationwide | 3,341 | 0 | 86,738 | 0 | Abstain |
| Voya | 0 | 0 | 57,070 | 0 | Abstain |
| Northern Trust | 0 | 0 | 55,991 | 0 | Abstain |
| T. Rowe Price | 0 | 0 | 55,067 | 0 | Abstain |
| AQR | 0 | 0 | 41,896 | 0 | Abstain |
| Pacific Life | 0 | 0 | 40,292 | 0 | Abstain |
| Bridge Builder Trust | 0 | 0 | 39,850 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 37,079 | 0 | Abstain |
| Russell Investments | 36,657 | 0 | 0 | 0 | For |
| Invesco | 35,570 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.
Combines 6 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Editas Medicine, Inc.’s own tally for this item (“Elect Director: Elliott Levy, M.D.”): 37,095,058 for, 2,354,672 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 97,866,996 outstanding shares: 38% for, 2% withheld (40% of the company cast a for/withheld vote).
The 46 asset managers below cast 100% of the shares they voted on this item FOR (16,510,339 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,326,832 | 0 | 5 | 0 | For |
| Fidelity | 2,183,498 | 0 | 0 | 0 | For |
| BlackRock | 1,960,033 | 0 | 0 | 0 | For |
| TIAA | 1,903,318 | 0 | 0 | 0 | For |
| Charles Schwab | 862,565 | 0 | 0 | 0 | For |
| JPMorgan | 588,540 | 0 | 0 | 0 | For |
| Equitable | 154,726 | 0 | 104,610 | 0 | For |
| Brighthouse | 123,581 | 0 | 9,034 | 0 | For |
| Lincoln Financial | 127,677 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 126,000 | 0 | 0 | 0 | For |
| SEI | 108,986 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,885 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 104,989 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 95,483 | 0 | 0 | 0 | For |
| Global X | 92,273 | 0 | 0 | 0 | For |
| Nationwide | 90,079 | 0 | 0 | 0 | For |
| Voya | 57,070 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 55,991 | 0 | Abstain |
| T. Rowe Price | 55,067 | 0 | 0 | 0 | For |
| AQR | 41,896 | 0 | 0 | 0 | For |
| Pacific Life | 40,292 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Goldman Sachs | 37,079 | 0 | 0 | 0 | For |
| Russell Investments | 36,657 | 0 | 0 | 0 | For |
| Invesco | 35,570 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.
Ranked by the number of Editas Medicine, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 97,866,996 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.19% |
| 2 | BlackRock | 5.66% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 2.51% |
| 4 | Fidelity | 2.33% |
| 5 | Nuveen | 2.02% |
| 6 | TIAA | 1.94% |
| 7 | Charles Schwab | 1.76% |
| 8 | State Street | 1.45% |
| 9 | ACADIAN ASSET MANAGEMENT LLC | 1.13% |
| 10 | KENNEDY CAPITAL MANAGEMENT LLC | 0.89% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Commodore Capital LP | 16.40% | 13G |
| TCG Crossover GP III, LLC | 16.14% | 13G |
| BlackRock | 9.47% | 13F |
| RA Capital Management, L.P. | 9.08% | 13G |
| Vanguard Group | 8.39% | 13F |
| Renaissance Technologies | 4.06% | 13F |
| Geode Capital | 2.36% | 13F |
| State Street | 2.12% | 13F |
| JPMorgan Chase | 1.99% | 13F |
| D.E. Shaw | 1.99% | 13F |
Percentages above are of 97,866,996 shares outstanding, as reported by Editas Medicine, Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Editas Medicine, Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Editas Medicine, Inc.'s shareholder meeting held 2026-06-17, in the 2025-2026 proxy season, 237 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 838 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE… — FOR was 84% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Editas Medicine, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-18.
Editas Medicine, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).